secwatch.observer — SEC 8-K summary
======================================

Issuer:     AtriCure, Inc. (ATRC)
CIK:        0001323885
Form:       8-K
Filed at:   2023-01-09T23:59:59+00:00
Accession:  0001323885-23-000008
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AtriCure reports Q4 2022 preliminary revenue $88M (+20% YoY); guides 2023 rev $380-387M
--------------------------------------------------------------------------------

- Q4 2022 revenue ~$88M (U.S. $73.9M, intl $14.1M), up 20% YoY.
- FY2022 revenue $330.4M, up 20% YoY; adjusted EBITDA loss ~$4M.
- Adjusted loss per share for FY2022 estimated at $1.10–$1.12.
- 2023 guidance: revenue $380–$387M, growth 15–17%; EBITDA breakeven.
- CEO cites strong demand across product lines; outlook reflects continued momentum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1323885/000132388523000008/0001323885-23-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1323885/000132388523000008/atrc-20230109.htm
  HTML page:      https://secwatch.observer/filing/0001323885-23-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer